Yoe Sik Bae

Title: Yoe Sik Bae: Innovator in Pharmaceutical Composition

Introduction

Yoe Sik Bae is a notable inventor based in Seongnam-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions aimed at treating inflammatory diseases and infections. With a total of 3 patents, his work showcases innovative approaches to health and medicine.

Latest Patents

Yoe Sik Bae's latest patents include a pharmaceutical composition designed for preventing or treating inflammatory diseases or infectious diseases. This composition contains m-3M3FBS, an activator of phospholipase C, as its active ingredient. The composition is intended to provide health supplements that improve or prevent these diseases, leveraging the microbicidal effect of m-3M3FBS. Additionally, he has developed a composition for treating sepsis or septic shock, which comprises a peptide derived from Smad6. This peptide specifically binds to Pellino-1, making it effective in treating sepsis mediated by excessively activated TLR, while also reducing inflammatory cytokine expression and protecting cells from sepsis-induced apoptosis.

Career Highlights

Throughout his career, Yoe Sik Bae has worked with esteemed institutions such as Sungkyunkwan University and Medpacto Inc. His research and innovations have positioned him as a key figure in the pharmaceutical industry, contributing to advancements in medical treatments.

Collaborations

Yoe Sik Bae has collaborated with notable colleagues, including Sang Doo Kim and Seok Hee Park. These partnerships have further enhanced his research and development efforts in the pharmaceutical field.

Conclusion

Yoe Sik Bae's contributions to pharmaceutical compositions demonstrate his commitment to advancing medical science. His innovative patents reflect a deep understanding of the complexities of inflammatory diseases and infections, paving the way for future developments in healthcare.